NCT05642884 Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
| NCT ID | NCT05642884 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Noha Mohamed Sharafeldin |
| Condition | Multiple Myeloma |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-07-10 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-07-10 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Multiple Myeloma * Scheduled for ASCT at UAB within 10 weeks of study enrollment * age at ASCT ≥60y Exclusion Criteria: * at high risk for impending pathologic fracture using Mirels score
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05642884 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Multiple Myeloma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05642884 currently recruiting?
Yes, NCT05642884 is actively recruiting participants. Contact the research team at landoncmartin@uabmc.edu for enrollment information.
Where is the NCT05642884 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT05642884 clinical trial?
NCT05642884 is sponsored by Noha Mohamed Sharafeldin. The trial plans to enroll 30 participants.